Open App →
Back to News Feed
PR Newswire November 19, 2026 neutral

Astrosalva Therapeutics Adds Alexander Disease Scientist Natasha Snider, PhD, to Scientific Advisory Board

Edge AI
<p>UNC-Chapel Hill researcher studies GFAP, the protein whose mutations cause Alexander disease SAN MATEO, Calif., Nov. 19, 2026 /PRNewswire/ -- Astrosalva Therapeutics, Inc. ("Astrosalva"), a privately held, preclinical biotechnology company developing treatments for Alexander disease (AxD)...</p>
Read original article ↗

Related Articles

Limina Adds Amberflo's AI Metering Technology to Extend Data Governance and Lineage Across Enterprise AI

Built by former AWS metering leaders and already embedded in the Limina platform, Amberflo's technology takes Limina bey

PR Newswire · November 19, 2026

BMO Uses IBM Quantum Computers to Identify Which Inputs Matter Most to AI Models

TORONTO, CHICAGO and SAN FRANCISCO, Nov. 19, 2026 — BMO today announced it has demonstrated quantum utility in a machine

HPC Wire · November 19, 2026

AtomVie Global Radiopharma et ITM concluent un accord d'approvisionnement pour du lutétium-177 n.c.a.

HAMILTON, Ontario, et GARCHING, Allemagne, 19 novembre 2026 /PRNewswire/ -- AtomVie Global Radiopharma (AtomVie), une or

PR Newswire · November 19, 2026

AtomVie Global Radiopharma e ITM suscriben un acuerdo de suministro para lutecio-177 n.c.a.

HAMILTON, ON y GARCHING, Alemania, 19 de noviembre de 2026 /PRNewswire/ -- AtomVie Global Radiopharma (AtomVie), una org

PR Newswire · November 19, 2026